Biotech

All Articles

Rivus' stage 2 obesity-related heart failure trial reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its fat-busting, muscle-sparing medi...

Ovid halts preclinical work, IV course after soticlestat fail

.Ovid Therapeutics presently showed final month that it was trimming its head count as the company b...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened a $700 thousand R&ampD facility in the Boston ma Seaport, boosting its own RNA...

Boundless Bio produces 'small' cutbacks 5 months after $100M IPO

.Only 5 months after securing a $100 million IPO, Boundless Bio is actually presently giving up some...

Halda's $126M will certainly advance 'secure as well as eliminate' growth drugs

.The first stages of oncology R&ampD may not be short of intriguing new modalities, and also Halda R...

Lykos 'regrets' certainly not divulging study infractions with publisher

.Psychopharmacology has drawn three articles regarding midstage medical trial information examining ...

Analysts dig into Avidity's DMD succeed, disclosing distinctions in data

.Avidity Biosciences impressed clients along with period 1/2 records in Duchenne muscular dystrophy ...

Actinogen's cortisol blocker stops working phase 2 anxiety study

.Actinogen Medical's cortisol blocker has actually missed the key endpoint of a stage 2 research stu...

Bivictrix makes a decision going exclusive only method to take ADC in to facility

.Antibody-drug conjugates (ADCs) have actually gone to the center of several a billion-dollar biobuc...

TPG leadings up funds to $580M for investments across life sciences

.Resource supervisor TPG, which has actually supported biotechs including Sionna Therapeutics and al...